Explaining human recreational use of 'pesticides': The neurotoxin regulation model of substance use vs. the hijack model and implications for age and sex differences in drug consumption

Frontiers in Psychiatry

Volumn 4, Issue NOV, 2013, Pages

  Hagen, Edward H ^a   Roulette, Casey J ^a   Sullivan, Roger J ^b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Drug reward; Evolution; Evolutionary medicine; pharmacophagy; Self medication; Zoopharmacognosy

Indexed keywords

NEUROTOXIN; NICOTINE; PESTICIDE;

ADULTHOOD; AGE DISTRIBUTION; ALCOHOL ABUSE; ARTICLE; CHILDHOOD; DEFENSE MECHANISM; DRUG DEPENDENCE; ENVIRONMENTAL EXPOSURE; EVOLUTION; FITNESS; HUMAN; MAJOR DEPRESSION; MATERNAL AGE; MENOPAUSE; NEUROBIOLOGY; NONHUMAN; PREGNANCY OUTCOME; PROTEIN FAMILY; REINFORCEMENT; REWARD; SEX DIFFERENCE; TERATOGENICITY; TOBACCO DEPENDENCE; TOXICOKINETICS; XENOBIOTIC METABOLISM;

EID: 84889680194     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2013.00142     Document Type: Article

References (253)

1. Glimcher PW. Colloquium paper: understanding dopamine and reinforcement learning: the dopamine reward prediction error hypothesis. Proc Natl Acad Sci U S A (2011) 108(Suppl 3):15647-54. doi: 10.1073/pnas.1014269108
2. Morris G, Schmidt R, Bergman H. Striatal action-learning based on dopamine concentration. Exp Brain Res (2009) 200:307-17. doi:10.1007/s00221-009-2060-6
3. Redgrave P, Gurney K, Reynolds J. What is reinforced by phasic dopamine signals? Brain Res Rev (2008) 58(2):322-39. doi:10.1016/j.brainresrev.2007.10.007
4. Schultz W. Behavioral dopamine signals. Trends Neurosci (2007) 30(5):203-10. doi:10.1016/j.tins.2007.03.007
5. Berridge KC. The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology (Berl) (2007) 191(3):391-431. doi:10.1007/s00213-006-0578-x
6. Salamone JD, Correa M, Farrar A, Mingote SM. Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology (2007) 191(3):461-82. doi:10.1007/s00213-006-0668-9
7. Schultz W. Potential vulnerabilities of neuronal reward, risk, and decision mechanisms to addictive drugs. Neuron (2011) 69(4):603-17. doi:10.1016/j.neuron.2011.02.014
8. Wise RA. Addiction becomes a brain disease. Neuron (2000) 26(1):27-33. doi:10.1016/S0896-6273(00)81134-4
9. Kelley AE, Berridge KC. The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci (2002) 22(9):3306-11.
10. Gardner E. Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharmacol Biochem Behav (2005) 81(2):263-84. doi:10.1016/j.pbb.2005.01.032
11. Hyman SE. Addiction: a disease of learning and memory. Am J Psychiatry (2005) 162:1414-22. doi:10.1176/appi.ajp.162.8.1414
12. Kauer JA, Malenka RC. Synaptic plasticity and addiction. Nat Rev Neurosci (2007) 8(11):844-58. doi:10.1038/nrn2234
13. Sulzer D. How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron (2011) 69(4):628-49. doi:10.1016/j.neuron.2011.02.010
14. Volkow ND, Baler RD, Goldstein RZ. Addiction: pulling at the neural threads of social behaviors. Neuron (2011) 69(4):599-602. doi:10.1016/j.neuron.2011.01.027
15. Goldstein RZ, Volkow ND. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci (2011) 12(11):652-69. doi:10.1038/nrn3119
16. Orr HA. Fitness and its role in evolutionary genetics. Nat Rev Genet (2009) 10(8):531-9. doi:10.1038/nrg2603
17. Avena NM, Rada P, Hoebel BG. Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake. Neurosci Biobehav Rev (2008) 32(1):20-39. doi:10.1016/j.neubiorev.2007.04.019
18. Ahmed SH, Avena DNM, Berridge DKC, Gearhardt DAN, Guillem DK. Food addiction. In: Pfaff DW, editor. Neuroscience in the 21st Century. New York: Springer (2013). p. 2833-57.
19. Ahmed SH, Lenoir M, Guillem K. Neurobiology of addiction versus drug use driven by lack of choice. Curr Opin Neurobiol (2013) 23(4):581-7. doi:10.1016/j.conb.2013.01.028
20. Sullivan RJ, Hagen EH. Psychotropic substance-seeking: evolutionary pathology or adaptation? Addiction (2002) 97:389-400. doi:10.1046/j.1360-0443.2002.00024.x
21. Sullivan RJ, Hagen EH, Hammerstein P. Revealing the paradox of drug reward in human evolution. Proc Biol Sci (2008) 275:1231-41. doi:10.1098/rspb.2007.1673
22. Hagen EH, Sullivan RJ, Schmidt R, Morris G, Kempter R, Hammerstein P. Ecology and neurobiology of toxin avoidance and the paradox of drug reward. Neuroscience (2009) 160:69-84. doi:10.1016/j.neuroscience.2009.01.077
23. West R. Theories of addiction. Addiction (2001) 96(1):3-13. doi:10.1046/j.1360-0443.2001.96131.x
24. Wink M. Interference of alkaloids with neuroreceptors and ion channels. In: ur Rahman A, editor. Bioactive Natural Products (Part B) (Vol. 21). Amsterdam: Elsevier (2000). p. 3-122.
25. Karban R, Agrawal AA. Herbivore offense. Annu Rev Ecol Syst (2002) 33:641-64. doi:10.1146/annurev.ecolsys.33.010802.150443
26. Petzinger E, Geyer J. Drug transporters in pharmacokinetics. Naunyn Schmiedebergs Arch Pharmacol (2006) 372(6):465-75. doi:10.1007/s00210-006-0042-9
27. Dauchy S, Dutheil F, Weaver RJ, Chassoux F, Daumas-Duport C, Couraud P-O, et al. ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem (2008) 107(6):1518-28. doi:10.1111/j.1471-4159.2008.05720.x
28. Dehkordi O, Rose JE, Fatemi M, Allard JS, Balan KV, Young JK, et al. Neuronal expression of bitter taste receptors and downstream signaling molecules in the rat brainstem. Brain Res (2012) 1475:1-10. doi:10.1016/j.brainres.2012.07.038
29. Dutheil F, Beaune P, Loriot M-A. Xenobiotic metabolizing enzymes in the central nervous system: contribution of cytochrome P450 enzymes in normal and pathological human brain. Biochimie (2008) 90(3):426-36. doi:10.1016/j.biochi.2007.10.007
30. Singh N, Vrontakis M, Parkinson F, Chelikani P. Functional bitter taste receptors are expressed in brain cells. Biochem Biophys Res Commun (2011) 406(1):146-51. doi:10.1016/j.bbrc.2011.02.016
31. Janzen DH. Complications in interpreting the chemical defenses of trees against tropical arboreal plant-eating vertebrates. In: Montgomerie GC, editor. The Ecology of Arboreal Folivores. Washington, DC: Smithsonian Institution Press (1978). p. 73-84.
32. Wrangham RW, Nishida T. Aspilia spp. leaves: a puzzle in the feeding behavior of wild chimpanzees. Primates (1983) 24(2):276-82. doi:10.1007/BF02381090
33. Johns T. With Bitter Herbs They Shall Eat It: Chemical Ecology and the Origins of Human Diet and Medicine. Tucson: University of Arizona Press (1990).
34. Glander KE. Nonhuman primate self-medication with wild plant foods. In: Etkin NL , editor. Eating on the Wild Side: The Pharmacological, Ecologic, and Social Implications of Using Noncultigens. Tucson: University of Arizona Press (1994). p. 227-39.
35. Huffman MA. Current evidence for self-medication in primates: a multidisciplinary perspective. Am J Phys Anthropol (1997) 104(S25):171-200. doi:10.1002/(SICI)1096-8644(1997)25+<171::AID-AJPA7>3.3.CO;2-K
36. Ode PJ. Plant chemistry and natural enemy fitness: effects on herbivore and natural enemy interactions. Annu Rev Entomol (2006) 51:163-85. doi:10.1146/annurev.ento.51.110104.151110
37. Villalba JJ, Provenza FD. Self-medication and homeostatic behaviour in herbivores: learning about the benefits of nature's pharmacy. Animal (2007) 1(09):1360-70. doi:10.1017/S1751731107000134
38. Huffman MA. Primate self-medication. In: Campbell C, Fuentes A, MacKinnon K, Panger M, Bearder S, editors. Primates in Perspective. Oxford: University of Oxford Press (2007). p. 677-90.
39. Singer MS, Mace KC, Bernays EA. Self-medication as adaptive plasticity: increased ingestion of plant toxins by parasitized caterpillars. PLoS One (2009) 4(3):e4796. doi:10.1371/journal.pone.0004796
40. Milan NF, Kacsoh BZ, Schlenke TA. Alcohol consumption as self-medication against blood-borne parasites in the fruit fly. Curr Biol (2012) 22(6):488-93. doi:10.1016/j.cub.2012.01.045
41. Kacsoh BZ, Lynch ZR, Mortimer NT, Schlenke TA. Fruit flies medicate offspring after seeing parasites. Science (2013) 339(6122):947-50. doi:10.1126/science.1229625
42. Suárez-Rodríguez M, López-Rull I, Garcia CM. Incorporation of cigarette butts into nests reduces nest ectoparasite load in urban birds: new ingredients for an old recipe? Biol Lett (2013) 9(1):20120931. doi:10.1098/rsbl.2012.0931
43. de Roode JC, Lefevre T, Hunter MD. Self-medication in animals. Science (2013) 340(6129):150-1. doi:10.1126/science.1235824
44. Castella G, Chapuisat M, Christe P. Prophylaxis with resin in wood ants. Anim Behav (2008) 75(4):1591-6. doi:10.1016/j.anbehav.2007.10.014
45. Lefèvre T, Chiang A, Kelavkar M, Li H, Li J, de Castillejo CLF, et al. Behavioural resistance against a protozoan parasite in the monarch butterfly. J Anim Ecol (2012) 81(1):70-9. doi:10.1111/j.1365-2656.2011.01901.x
46. Lefevre T, Oliver L, Hunter MD, de Roode JC. Evidence for trans-generational medication in nature. Ecol Lett (2010) 13(12):1485-93. doi:10.1111/j.1461-0248.2010.01537.x
47. Köhler A, Pirk CW, Nicolson SW. Honeybees and nectar nicotine: deterrence and reduced survival versus potential health benefits. J Insect Physiol (2012) 58(2):286-92. doi:10.1016/j.jinsphys.2011.12.002
48. Simone-Finstrom MD, Spivak M. Increased resin collection after parasite challenge: a case of self-medication in honey bees? PLoS One (2012) 7(3):e34601. doi:10.1371/journal.pone.0034601
49. Villalba JJ, Provenza FD, Hall JO, Lisonbee LD. Selection of tannins by sheep in response to gastrointestinal nematode infection. J Anim Sci (2010) 88(6):2189-98. doi:10.2527/jas.2009-2272
50. Villalba JJ, Landau SY. Host behavior, environment and ability to self-medicate. Small Rumin Res (2012) 103(1):50-9. doi:10.1016/j.smallrumres.2011.10.018
51. Hardy K, Buckley S, Collins MJ, Estalrrich A, Brothwell D, Copeland L, et al. Neanderthal medics? Evidence for food, cooking, and medicinal plants entrapped in dental calculus. Naturwissenschaften (2012) 99(8):617-26. doi:10.1007/s00114-012-0942-0
52. Parker BJ, Barribeau SM, Laughton AM, de Roode JC, Gerardo NM. Non-immunological defense in an evolutionary framework. Trends Ecol Evol (2011) 26:242-8. doi:10.1016/j.tree.2011.02.005
53. Schaller M, Duncan LA, Schaller M, Duncan LA. The behavioral immune system: its evolution and social psychological implications. In: Forgas JP, Haselton MG, von Hippel W, editors. Evolution and the Social Mind: Evolutionary Psychology and Social Cognition. New York, NY: Psychology Press (2007). p. 293-307.
54. Baldwin IT. An ecologically motivated analysis of plant-herbivore interactions in native tobacco. Plant Physiol (2001) 127(4):1449-58. doi:10.1104/pp.010762
55. Steppuhn A, Gase K, Krock B, Halitschke R, Baldwin IT. Nicotine's defensive function in nature. PLoS Biol (2004) 2(8):E217. doi:10.1371/journal.pbio.0020217
56. Gosselin RE, Smith RP, Hodge HC. Clinical Toxicology of Commercial Products. 5th ed. (Vol. II). Baltimore, MD: Williams and Wilkin (1984).
57. de Landoni JH. Nicotine. Poisons Information Monographs, International Programme on Chemical Safety (1991). Available from: http://www.inchem.org/documents/pims/chemical/nicotine.htm
58. Hukkanen J, Jacob P, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacol Rev (2005) 57(1):79-115. doi:10.1124/pr.57.1.3
59. Wilbert J. Tobacco and Shamanism in South America. New Haven, CT: Yale University Press (1987).
60. Winter JC. Tobacco Use by Native North Americans: Sacred Smoke and Silent Killer. Norman: University of Oklahoma Press (2000).
61. Lewis RS, Nicholson JS. Aspects of the evolution of Nicotiana tabacum L. and the status of the United States Nicotiana germplasm collection. Genet Resour Crop Evol (2006) 54(4):727-40. doi:10.1007/s10722-006-0024-2
62. Wu SV, Rozengurt N, Yang M, Young SH, Sinnett-Smith J, Rozengurt E. Expression of bitter taste receptors of the T2R family in the gastrointestinal tract and enteroendocrine STC-1 cells. Proc Natl Acad Sci U S A (2002) 99(4):2392-7. doi:10.1073/pnas.042617699
63. Oliveira-Maia AJ, Stapleton-Kotloski JR, Lyall V, Phan TT, Mummalaneni S, Melone P, et al. Nicotine activates TRPM5-dependent and independent taste pathways. Proc Natl Acad Sci U S A (2009) 106(5):1596-601. doi:10.1073/pnas.0810184106
64. Lamba V. PXR (NR1I2): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activators. Toxicol Appl Pharmacol (2004) 199(3):251-65. doi:10.1016/j.taap.2003.12.027
65. Laviolette SR, van der Kooy D. The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour. Nat Rev Neurosci (2004) 5(1):55-65. doi:10.1038/nrn1298
66. Kumar R, Pratt JA, Stolerman IP. Characteristics of conditioned taste aversion produced by nicotine in rats. Br J Pharmacol (1983) 79(1):245-53. doi:10.1111/j.1476-5381.1983.tb10518.x
67. Foulds J, Stapleton JA, Bell N, Swettenham J, Jarvis MJ, Russell MAH. Mood and physiological effects of subcutaneous nicotine in smokers and never-smokers. Drug Alcohol Depend (1997) 44(2-3):105-15. doi:10.1016/S0376-8716(96)01327-0
68. Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer (2003) 3(10):733-44. doi:10.1038/nrc1190
69. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol (2004) 43(10):1731-7. doi:10.1016/j.jacc.2003.12.047
70. Verendeev A, Riley AL. Conditioned taste aversion and drugs of abuse: history and interpretation. Neurosci Biobehav Rev (2012) 36(10):2193-205. doi:10.1016/j.neubiorev.2012.08.004
71. Davis CM, Riley AL. Conditioned taste aversion learning: implications for animal models of drug abuse. Ann N Y Acad Sci (2010) 1187(1):247-75. doi:10.1111/j.1749-6632.2009.05147.x
72. Hunt T, Amit Z. Conditioned taste aversion induced by self-administered drugs: paradox revisited. Neurosci Biobehav Rev (1987) 11(1):107-30. doi:10.1016/S0149-7634(87)80005-2
73. Provenza FD, Balph DF. Diet learning by domestic ruminants: theory, evidence and practical implications. Appl Anim Behav Sci (1987) 18(3):211-32. doi:10.1016/0168-1591(87)90218-8
74. Forbey JS, Dearing MD, Gross EM, Orians CM, Sotka EE, Foley WJ. A pharm-ecological perspective of terrestrial and aquatic plant-herbivore interactions. J Chem Ecol (2013) 39(4):465-80. doi:10.1007/s10886-013-0267-2
75. Torregrossa A-M, Azzara AV, Dearing MD. Testing the diet-breadth trade-off hypothesis: differential regulation of novel plant secondary compounds by a specialist and a generalist herbivore. Oecologia (2012) 168(3):711-8. doi:10.1007/s00442-011-2121-y
76. Torregrossa A-M, Dearing MD. Nutritional toxicology of mammals: regulated intake of plant secondary compounds. Funct Ecol (2009) 23(1):48-56. doi:10.1111/j.1365-2435.2008.01523.x
77. Forbey JS, Harvey AL, Huffman MA, Provenza FD, Sullivan R, Tasdemir D. Exploitation of secondary metabolites by animals: a response to homeostatic challenges. Integr Comp Biol (2009) 49(3):314-28. doi:10.1093/icb/icp046
78. Raubenheimer D, Simpson SJ. Nutritional PharmEcology: doses, nutrients, toxins, and medicines. Integr Comp Biol (2009) 49(3):329-37. doi:10.1093/icb/icp050
79. Gable RS. Comparison of acute lethal toxicity of commonly abused psychoactive substances. Addiction (2004) 99(6):686-96. doi:10.1111/j.1360-0443.2004.00744.x
80. Darke S, Kaye S, Duflou J. Cocaine-related fatalities in New South Wales, Australia 1993-2002. Drug Alcohol Depend (2005) 77(2):107-14. doi:10.1016/j.drugalcdep.2004.07.004
81. Tsibulsky VL, Norman AB. Satiety threshold: a quantitative model of maintained cocaine self-administration. Brain Res (1999) 839(1):85-93. doi:10.1016/S0006-8993(99)01717-5
82. Rodriguez E, Cavin JC, West JE. The possible role of Amazonian psychoactive plants in the chemotherapy of parasitic worms-a hypothesis. J Ethnopharmacol (1982) 6(3):303-9. doi:10.1016/0378-8741(82)90053-8
83. Mascie-Taylor CGN. The burden of chronic disease. Science (2003) 302:1921-2. doi:10.1126/science.1092488
84. Jackson J, Friberg I, Little S, Bradley J. Review series on helminths, immune modulation and the hygiene hypothesis: immunity against helminths and immunological phenomena in modern human populations: coevolutionary legacies? Immunology (2009) 126(1):18-27. doi:10.1111/j.1365-2567.2008.03010.x
85. Hotez PJ, Brindley PJ, Bethony JM, King CH, Pearce EJ, Jacobson J. Helminth infections: the great neglected tropical diseases. J Clin Invest (2008) 118(4):1311-21. doi:10.1172/JCI34261
86. Maizels RM, Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol (2003) 3(9):733-44. doi:10.1038/nri1183
87. Yazdanbakhsh M, Sacks DL. Why does immunity to parasites take so long to develop? Nat Rev Immunol (2010) 10(2):80-1. doi:10.1038/nri2673
88. Debban CL, Dyer KA. No evidence for behavioural adaptations to nematode parasitism by the fly Drosophila putrida. J Evol Biol (2013) 26(8):1646-54. doi:10.1111/jeb.12158
89. Hammond JA, Fielding D, Bishop SC. Prospects for plant anthelmintics in tropical veterinary medicine. Vet Res Commun (1997) 21:213-28. doi:10.1023/A:1005884429253
90. World Health Organization. Guidelines for surveillance, prevention and control of echinococcosis/hydatidosis. In: Eckert J, Gemmell MA, Soulsby EJL, editors. Echinococcosis-Hydatidosis Surveillance, Prevention and Control. FAO/UNEP/WHO (1981). Available from: http://apps.who.int/iris/handle/10665/66490
91. Iqbal Z, Lateef M, Jabbar A, Ghayur MN, Gilani AH. In vitro and in vivo anthelmintic activity of Nicotiana tabacum L. leaves against gastrointestinal nematodes of sheep. Phytother Res (2006) 20(1):46-8. doi:10.1002/ptr.1800
92. Msolla P, Mmbuji WE, Kasuku AA. Field control of bovine parasitic otitis. Trop Anim Health Prod (1987) 19(3):179-83. doi:10.1007/BF02239717
93. Kabelik J, Krejei Z, Santavy F. Cannabis as a medicament. Bull Narc (1960) 12:5-23.
94. Kohler P. The biochemical basis of anthelmintic action and resistance. Int J Parasitol (2001) 31(4):336-45. doi:10.1016/S0020-7519(01)00131-X
95. Tomizawa M, Casida JE. Neonicotinoid insecticide toxicology: mechanisms of selective action. Annu Rev Pharmacol Toxicol (2005) 45:247-68. doi:10.1146/annurev.pharmtox.45.120403.095930
96. Grewal PS. Nematicidal effects of some plant-extracts to Aphelenchoides composticola (nematoda) infesting mushroom, Agaricus bisporus. Rev Nematol (1989) 12(3):317-22.
97. McPartland JM. Cannabis as repellent and pesticide. J Int Hemp Assoc (1997) 4(2):89-94.
98. McPartland JM, Glass M. Nematicidal effects of hemp (Cannabis sativa) may not be mediated by cannabinoid receptors. N Z J Crop Hortic Sci (2001) 29:301-7. doi:10.1080/01140671.2001.9514191
99. Berna F, Goldberg P, Horwitz LK, Brink J, Holt S, Bamford M, et al. Microstratigraphic evidence of in situ fire in the Acheulean strata of Wonderwerk Cave, Northern Cape province, South Africa. Proc Natl Acad Sci U S A (2012) 109(20):E1215-20. doi:10.1073/pnas.1117620109
100. Goren-Inbar N, Alperson N, Kislev ME, Simchoni O, Melamed Y, Ben-Nun A, et al. Evidence of hominin control of fire at Gesher Benot Yaaqov, Israel. Science (2004) 304(5671):725-7.
101. Friedman H, Newton C, Klein TW. Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev (2003) 16(2):209-19. doi:10.1128/CMR.16.2.209-219.2003
102. Hutchinson MR, Watkins LR. Why is neuroimmunopharmacology crucial for the future of addiction research? Neuropharmacology (2013) 76(Pt B):218-27. doi:10.1016/j.neuropharm.2013.05.039
103. Coller JK, Hutchinson MR. Implications of central immune signaling caused by drugs of abuse: mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence. Pharmacol Ther (2012) 134(2):219-45. doi:10.1016/j.pharmthera.2012.01.008
104. Mayfield J, Ferguson L, Harris RA. Neuroimmune signaling: a key component of alcohol abuse. Curr Opin Neurobiol (2013) 23(4):513-20. doi:10.1016/j.conb.2013.01.024
105. Hutchinson MR, Northcutt AL, Hiranita T, Wang X, Lewis SS, Thomas J, et al. Opioid activation of toll-like receptor 4 contributes to drug reinforcement. J Neurosci (2012) 32(33):11187-200. doi:10.1523/JNEUROSCI.0684-12.2012
106. Blednov YA, Ponomarev I, Geil C, Bergeson S, Koob GF, Harris RA. Neuroimmune regulation of alcohol consumption: behavioral validation of genes obtained from genomic studies. Addict Biol (2012) 17(1):108-20. doi:10.1111/j.1369-1600.2010.00284.x
107. Blednov YA, Benavidez JM, Geil C, Perra S, Morikawa H, Harris RA. Activation of inflammatory signaling by lipopolysaccharide produces a prolonged increase of voluntary alcohol intake in mice. Brain Behav Immun (2011) 25:S92-105. doi:10.1016/j.bbi.2011.01.008
108. Liu YZ, Pei YF, Guo YF, Wang L, Liu XG, Yan H, et al. Genome-wide association analyses suggested a novel mechanism for smoking behavior regulated by IL15. Mol Psychiatry (2009) 14(7):668-80. doi:10.1038/mp.2009.3
109. Morgan ET, Goralski KB, Piquette-Miller M, Renton KW, Robertson GR, Chaluvadi MR, et al. Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab Dispos (2008) 36(2):205-216. doi:10.1124/dmd.107.018747
110. Scherer G. Smoking behaviour and compensation: a review of the literature. Psychopharmacology (1999) 145(1):1-20. doi:10.1007/s002130051027
111. Joshua M, Adler A, Mitelman R, Vaadia E, Bergman H. Midbrain dopaminergic neurons and striatal cholinergic interneurons encode the difference between reward and aversive events at different epochs of probabilistic classical conditioning trials. J Neurosci (2008) 28(45):11673-84. doi:10.1523/JNEUROSCI.3839-08.2008
112. Brischoux F, Chakraborty S, Brierley DI, Ungless MA. Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli. Proc Natl Acad Sci U S A (2009) 106(12):4894-9. doi:10.1073/pnas.0811507106
113. Matsumoto M, Hikosaka O. Two types of dopamine neuron distinctly convey positive and negative motivational signals. Nature (2009) 459(7248):837-41. doi:10.1038/nature08028
114. Schmidt R, Morris G, Hagen EH, Sullivan RJ, Hammerstein P, Kempter R. The dopamine puzzle. Proc Natl Acad Sci U S A (2009) 106(27):E75. doi:10.1073/pnas.0905153106
115. McCarron DA. Physiology, not policy, drives sodium intake. Am J Hypertens (2013) 26(10):1191-3. doi:10.1093/ajh/hpt151
116. Geerling JC, Loewy AD. Central regulation of sodium appetite. Exp Physiol (2008) 93(2):177-209. doi:10.1113/expphysiol.2007.039891
117. Muster W, Breidenbach A, Fischer H, Kirchner S, Müller L, Pähler A. Computational toxicology in drug development. Drug Discov Today (2008) 13(7-8):303-10. doi:10.1016/j.drudis.2007.12.007
118. Meyerhof W, Batram C, Kuhn C, Brockhoff A, Chudoba E, Bufe B, et al. The molecular receptive ranges of human TAS2R bitter taste receptors. Chem Senses (2010) 35:157-70. doi:10.1093/chemse/bjp092
119. Ahmed SH, Koob GF. Transition from moderate to excessive drug intake: change in hedonic set point. Science (1998) 282(5387):298-300. doi:10.1126/science.282.5387.298
120. Degenhardt L, Chiu WT, Sampson N, Kessler RC, Anthony JC, Angermeyer M, et al. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med (2008) 5(7):e141. doi:10.1371/journal.pmed.0050141
121. Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev (1996) 18(2):188-204. doi:10.1093/oxfordjournals.epirev.a017925
122. Marano C, Schober SE, Brody DJ, Zhang C. Secondhand tobacco smoke exposure among children and adolescents: United states, 2003-2006. Pediatrics (2009) 124(5):1299-305. doi:10.1542/peds.2009-0880
123. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (1999-2010). Available from: http://www.cdc.gov/nchs/nhanes/nhanes_questionnaires.htm
124. Jarvis MJ, Foulds J, Feyerabend C. Exposure to passive smoking among bar staff. Br J Addict (1992) 87(1):111-3. doi:10.1111/j.1360-0443.1992.tb01906.x
125. Ervin RB, Kit BK, Carroll MD. Consumption of Added Sugar Among Us Children and Adolescents, 2005-2008. Hyattsville, MD: National Center for Health Statistics (2012). NCHS Data Brief No. 87.
126. Wang YC, Bleich SN, Gortmaker SL. Increasing caloric contribution from sugar-sweetened beverages and 100% fruit juices among US children and adolescents, 1988-2004. Pediatrics (2008) 121(6):e1604-14. doi:10.1542/peds.2007-2834
127. Hämmerer D, Eppinger B. Dopaminergic and prefrontal contributions to reward-based learning and outcome monitoring during child development and aging. Dev Psychol (2012) 48(3):862-74. doi:10.1037/a0027342
128. Miller EK, Cohen JD. An integrative theory of prefrontal cortex function. Annu Rev Neurosci (2001) 24(1):167-202. doi:10.1146/annurev.neuro.24.1.167
129. Casey BJ, Jones RM, Hare TA. The adolescent brain. Ann N Y Acad Sci (2008) 1124:111-26. doi:10.1196/annals.1440.010
130. Steinberg L. A social neuroscience perspective on adolescent risk-taking. Dev Rev (2008) 28(1):78-106. doi:10.1016/j.dr.2007.08.002
131. Chambers RA, Taylor JR, Potenza MN. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry (2003) 160(6):1041-52. doi:10.1176/appi.ajp.160.6.1041
132. World Health Organization. WHO Report on the Global Tobacco Epidemic (2013). Available from: http://www.who.int/tobacco/global_report/2013/en/
133. Ashihara H, Sano H, Crozier A. Caffeine and related purine alkaloids: biosynthesis, catabolism, function and genetic engineering. Phytochemistry (2008) 69(4):841-56. doi:10.1016/j.phytochem.2007.10.029
134. Wright GA, Baker DD, Palmer MJ, Stabler D, Mustard JA, Power EF, et al. Caffeine in floral nectar enhances a pollinator's memory of reward. Science (2013) 339(6124):1202-4. doi:10.1126/science.1228806
135. Ferré S. An update on the mechanisms of the psychostimulant effects of caffeine. J Neurochem (2008) 105(4):1067-79. doi:10.1111/j.1471-4159.2007.05196.x
136. Knight CA, Knight I, Mitchell DC, Zepp JE. Beverage caffeine intake in US consumers and subpopulations of interest: estimates from the share of intake panel survey. Food Cosmet Toxicol (2004) 42(12):1923-30. doi:10.1016/j.fct.2004.05.002
137. Cipollini ML, Levey DJ. Secondary metabolites of fleshy vertebrate-dispersed fruits: adaptive hypotheses and implications for seed dispersal. Am Nat (1997) 150(3):346-72. doi:10.1086/286069
138. Butte NF, Wong WW, Hopkinson JM, Heinz CJ, Mehta NR, Smith EO. Energy requirements derived from total energy expenditure and energy deposition during the first 2 y of life. Am J Clin Nutr (2000) 72(6):1558-69.
139. World Health Organization and Others. Human Energy Requirements. Technical Report, Report of a Joint FAO/WHO/UNU Expert Consultation, Rome (2001). Available from: ftp://ftp.fao.org/docrep/fao/007/y5686e/y5686e00.pdf
140. Roberts DM, Buckley NA. Pharmacokinetic considerations in clinical toxicology. Clin Pharmacokinet (2007) 46(11):897-939. doi:10.2165/00003088-200746110-00001
141. Sorensen JS, McLister JD, Dearing MD. Plant secondary metabolites compromise the energy budgets of specialist and generalist mammalian herbivores. Ecology (2005) 86(1):125-39. doi:10.1890/03-0627
142. Slotkin TA, Levin ED, Seidler FJ. Comparative developmental neurotoxicity of organophosphate insecticides: effects on brain development are separable from systemic toxicity. Environ Health Perspect (2006) 114(5):746-51. doi:10.1289/ehp.8828
143. von Moos R, Stolz R, Cerny T, Gillessen S. Thalidomide: from tragedy to promise. Swiss Med Wkly (2003) 133(5/6):77-87.
144. Chung F, Lu J, Palmer BD, Kestell P, Browett P, Baguley BC, et al. Thalidomide pharmacokinetics and metabolite formation in mice, rabbits, and multiple myeloma patients. Clin Cancer Res (2004) 10(17):5949-56. doi:10.1158/1078-0432.CCR-04-0421
145. Slotkin TA. Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke, organophosphates. Toxicol Appl Pharmacol (2004) 198(2):132-51. doi:10.1016/j.taap.2003.06.001
146. Dwyer JB, Broide RS, Leslie FM. Nicotine and brain development. Birth Defects Res C Embryo Today (2008) 84(1):30-44. doi:10.1002/bdrc.20118
147. DiFranza JR, Aligne CA, Weitzman M. Prenatal and postnatal environmental tobacco smoke exposure and children's health. Pediatrics (2004) 113(Suppl 3):1007-15.
148. Chen R, Clifford A, Lang L, Anstey KJ. Is exposure to secondhand smoke associated with cognitive parameters of children and adolescents? A systematic literature review. Ann Epidemiol (2013) 23(10):652-61. doi:10.1016/j.annepidem.2013.07.001
149. Albuquerque EX, Pereira EFR, Alkondon M, Rogers SW. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev (2009) 89(1):73-120. doi:10.1152/physrev.00015.2008
150. Schirmer SU, Eckhardt I, Lau H, Klein J, DeGraaf YC, Lips KS, et al. The cholinergic system in rat testis is of non-neuronal origin. Reproduction (2011) 142(1):157-66. doi:10.1530/REP-10-0302
151. Cashdan E. Adaptiveness of food learning and food aversions in children. Soc Sci Inform (1998) 37(4):613-32. doi:10.1177/053901898037004003
152. Dovey TM, Staples PA, Gibson EL, Halford JC. Food neophobia and "picky/fussy" eating in children: a review. Appetite (2008) 50(2-3):181-93. doi:10.1016/j.appet.2007.09.009
153. Behrens M, Meyerhof W. Bitter taste receptor research comes of age: from characterization to modulation of TAS2Rs. Semin Cell Dev Biol (2013) 24(3):215-21. doi:10.1016/j.semcdb.2012.08.006
154. Drewnowski A, Gomez-Carneros C. Bitter taste, phytonutrients, and the consumer: a review. Am J Clin Nutr (2000) 72(6):1424-35.
155. Chandrashekar J, Hoon MA, Ryba NJP, Zuker CS. The receptors and cells for mammalian taste. Nature (2006) 444(7117):288-94. doi:10.1038/nature05401
156. Fox AL. The relationship between chemical constitution and taste. Proc Natl Acad Sci U S A (1932) 18(1):115-20. doi:10.1073/pnas.18.1.115
157. Blakeslee AF. Genetics of sensory thresholds: taste for phenylthiocarbamide. Proc Natl Acad Sci U S A (1932) 18:120-30. doi:10.1073/pnas.18.1.120
158. Wooding S. Phenylthiocarbamide: a 75-year adventure in genetics and natural selection. Genetics (2006) 172(4):2015-23.
159. Hayes JE, Bartoshuk LM, Kidd JR, Duffy VB. Supertasting and PROP bitterness depends on more than the TAS2R38 gene. Chem Senses (2008) 33(3):255-65. doi:10.1093/chemse/bjm084
160. Correa M, Hutchinson I, Laing DG, Jinks AL. Changes in fungiform papillae density during development in humans. Chem Senses (2013) 38(6):519-27. doi:10.1093/chemse/bjt022
161. Negri R, Di Feola M, Di Domenico S, Scala MG, Artesi G, Valente S, et al. Taste perception and food choices. J Pediatr Gastroenterol Nutr (2012) 54(5):624-9. doi:10.1097/MPG.0b013e3182473308
162. Mennella JA, Pepino MY, Reed DR. Genetic and environmental determinants of bitter perception and sweet preferences. Pediatrics (2005) 115(2):e216-22. doi:10.1542/peds.2004-1582
163. Mennella JA, Pepino MY, Duke FF, Reed DR. Age modifies the genotype-phenotype relationship for the bitter receptor TAS2R38. BMC Genet (2010) 11(1):60. doi:10.1186/1471-2156-11-60
164. Scinska A, Koros E, Habrat B, Kukwa A, Kostowski W, Bienkowski P. Bitter and sweet components of ethanol taste in humans. Drug Alcohol Depend (2000) 60(2):199-206. doi:10.1016/S0376-8716(99)00149-0
165. Johnson TN, Tucker GT, Tanner MS, Rostami-Hodjegan A. Changes in liver volume from birth to adulthood: a meta-analysis. Liver Transpl (2005) 11(12):1481-93. doi:10.1002/lt.20519
166. Ginsberg G, Hattis D, Sonawane B. Incorporating pharmacokinetic differences between children and adults in assessing children's risks to environmental toxicants. Toxicol Appl Pharmacol (2004) 198(2):164-83. doi:10.1016/j.taap.2003.10.010
167. Anderson BJ, Holford NHG. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol (2008) 48(1):303-32. doi:10.1146/annurev.pharmtox.48.113006.094708
168. Centers for Disease Control and Prevention. Web-based Injury Statistics Query and Reporting System (WISQARS). National Center for Injury Prevention and Control, Centers for Disease Control and Prevention (2003).
169. Anderson RM, May RM. Herd immunity to helminth infection and implications for parasite control. Nature (1985) 315(6019):493-6. doi:10.1038/315493a0
170. Woolhouse M. Patterns in parasite epidemiology: the peak shift. Parasitol Today (1998) 14(10):428-34. doi:10.1016/S0169-4758(98)01318-0
171. Blackwell AD, Gurven MD, Sugiyama LS, Madimenos FC, Liebert MA, Martin MA, et al. Evidence for a peak shift in a humoral response to helminths: age profiles of IgE in the Shuar of Ecuador, the Tsimane of Bolivia, and the U.S. NHANES. PLoS Negl Trop Dis (2011) 5(6):e1218. doi:10.1371/journal.pntd.0001218
172. Mitchell KM, Mutapi F, Savill NJ, Woolhouse MEJ. Protective immunity to Schistosoma haematobium infection is primarily an anti-fecundity response stimulated by the death of adult worms. Proc Natl Acad Sci U S A (2012) 109(33):13347-52. doi:10.1073/pnas.1121051109
173. Darwin C. The Descent of Man, and Selection in Relation to Sex. London: John Murray (1871).
174. Andersson MB. Sexual Selection. Princeton, NJ: Princeton University Press (1994).
175. Diamond JM. The Third Chimpanzee. New York: HarperCollins (1992).
176. Song AV, Morrell HER, Cornell JL, Ramos ME, Biehl M, Kropp RY, et al. Perceptions of smoking-related risks and benefits as predictors of adolescent smoking initiation. Am J Public Health (2009) 99(3):487-92. doi:10.2105/AJPH.2008.137679
177. Arbeau KJ, Galambos NL, Mikael Jansson S. Dating, sex, and substance use as correlates of adolescents' subjective experience of age. J Adolesc (2007) 30(3):435-47. doi:10.1016/j.adolescence.2006.04.006
178. Galambos NL, Kolaric GC, Sears HA, Maggs JL. Adolescents' subjective age: an indicator of perceived maturity. J Res Adolesc (1999) 9(3):309-37. doi:10.1207/s15327795jra0903_4
179. Hill EM, Chow K. Life-history theory and risky drinking. Addiction (2002) 97(4):401-13. doi:10.1046/j.1360-0443.2002.00020.x
180. Lende DH, Smith EO. Evolution meets biopsychosociality: an analysis of addictive behavior. Addiction (2002) 97(4):447-58. doi:10.1046/j.1360-0443.2002.00022.x
181. Wilson M, Daly M. Competitiveness, risk taking, and violence: the young male syndrome. Ethol Sociobiol (1985) 6(1):59-73. doi:10.1016/0162-3095(85)90041-X
182. Sussman S. The relations of cigarette smoking with risky sexual behavior among teens. Sex Addict Comp (2005) 12(2-3):181-99.
183. Jones DN, Figueredo AJ. Mating effort as a predictor of smoking in a college sample. Curr Res Soc Psychol (2007) 12:186-95.
184. Kurzban R, Dukes A, Weeden J. Sex, drugs and moral goals: reproductive strategies and views about recreational drugs. Proc Biol Sci (2010) 277(1699):3501-8. doi:10.1098/rspb.2010.0608
185. Dechanet C, Anahory T, Mathieu Daude JC, Quantin X, Reyftmann L, Hamamah S, et al. Effects of cigarette smoking on reproduction. Hum Reprod Update (2010) 17(1):76-95. doi:10.1093/humupd/dmq033
186. Cao S, Yin X, Wang Y, Zhou H, Song F, Lu Z. Smoking and risk of erectile dysfunction: systematic review of observational studies with meta-analysis. PLoS One (2013) 8(4):e60443. doi:10.1371/journal.pone.0060443
187. Vine MF. Smoking and male reproduction: a review. Int J Androl (1996) 19(6):323-37. doi:10.1111/j.1365-2605.1996.tb00523.x
188. Spence M. Job market signaling. Q J Econ (1973) 87(3):355-74. doi:10.2307/1882010
189. Zahavi A. Mate selection-a selection for a handicap. J Theor Biol (1975) 53:205-14. doi:10.1016/0022-5193(75)90111-3
190. Patja K, Hakala SM, Bostrom G, Nordgren P, Haglund M. Trends of tobacco use in Sweden and Finland: do differences in tobacco policy relate to tobacco use? Scand J Public Health (2009) 37(2):153-60. doi:10.1177/1403494808100277
191. Kandall SR. Substance and Shadow: Women and Addiction in the United States. Cambridge, MA: Harvard University Press (1999).
192. Cotto JH, Davis E, Dowling GJ, Elcano JC, Staton AB, Weiss SRB. Gender effects on drug use, abuse, and dependence: a special analysis of results from the National Survey on Drug Use and Health. Gend Med (2010) 7(5):402-13. doi:10.1016/j.genm.2010.09.004
193. Substance Abuse and Mental Health Services Administration. Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration (2012). NSDUH Series H-44 HHS Publication No. (SMA) 12-4713.
194. Gorber SC, Schofield-Hurwitz S, Hardt J, Levasseur G, Tremblay M. The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res (2009) 11(1):12-24. doi:10.1093/ntr/ntn010
195. Assaf AR, Parker D, Lapane KL, McKenney JL, Carleton RA. Are there gender differences in self-reported smoking practices? Correlation with thiocyanate and cotinine levels in smokers and nonsmokers from the Pawtucket Heart Health Program. J Womens Health (Larchmt) (2002) 11(10):899-906. doi:10.1089/154099902762203731
196. Gan WQ, Cohen SB-Z, Man SFP, Sin DD. Sex-related differences in serum cotinine concentrations in daily cigarette smokers. Nicotine Tob Res (2008) 10(8):1293-300. doi:10.1080/14622200802239132
197. Jung-Choi K-H, Khang Y-H, Cho H-J. Hidden female smokers in Asia: a comparison of self-reported with cotinine-verified smoking prevalence rates in representative national data from an Asian population. Tob Control (2012) 21(6):536-42. doi:10.1136/tobaccocontrol-2011-050012
198. Ervin RB, Ogden CL. Consumption of Added Sugars Among US Adults, 2005-2010. Hyattsville, MD: National Center for Health Statistics (2013). NCHS Data Brief No. 122.
199. Becker JB, Hu M. Sex differences in drug abuse. Front Neuroendocrinol (2008) 29(1):36-47. doi:10.1016/j.yfrne.2007.07.003
200. Becker JB, Taylor JR. Sex differences in motivation. In: Becker JB, Berkley KJ, Geary N, Hampson E, Herman JP, Young EA, editors. Sex Differences in the Brain: From Genes to Behavior. New York: Oxford University Press (2008). p. 177-99.
201. Becker JB. Sexual differentiation of motivation: a novel mechanism? Horm Behav (2009) 55(5):646-54. doi:10.1016/j.yhbeh.2009.03.014
202. Becker JB, Perry AN, Westenbroek C. Sex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesis. Biol Sex Differ (2012) 3(1):1-35. doi:10.1186/2042-6410-3-14
203. Trivers RL. Parental investment and sexual selection. In: Campbell B, Campbell B, editors. Sexual Selection and the Descent of Man 1871-1971. Chicago, IL: Aldine (1972). p. 139-79.
204. McClintock MK, Anisko JJ, Adler NT. Group mating among Norway rats. II. The social dynamics of copulation: competition, cooperation, and mate choice. Anim Behav (1982) 30(2):410-25. doi:10.1016/S0003-3472(82)80052-3
205. Marlowe FW. Hunter-gatherers and human evolution. Evol Anthropol Issues News Rev (2005) 14(2):54-67. doi:10.1002/evan.20046
206. Vyhlidal CA, Riffel AK, Haley KJ, Sharma S, Dai H, Tantisira KG, et al. Cotinine in human placenta predicts induction of gene expression in fetal tissues. Drug Metab Dispos (2013) 41(2):305-11. doi:10.1124/dmd.112.049999
207. Schulte-Hobein B, Schwartz-Bickenbach D, Abt S, Plum C, Nau H. Cigarette smoke exposure and development of infants throughout the first year of life: influence of passive smoking and nursing on cotinine levels in breast milk and infant's urine. Acta Paediatr (1992) 81(6-7):550-7. doi:10.1111/j.1651-2227.1992.tb12293.x
208. Clifford A, Lang L, Chen R. Effects of maternal cigarette smoking during pregnancy on cognitive parameters of children and young adults: a literature review. Neurotoxicol Teratol (2012) 34(6):560-70. doi:10.1016/j.ntt.2012.09.004
209. Intelmann D, Batram C, Kuhn C, Haseleu G, Meyerhof W, Hofmann T. Three TAS2R bitter taste receptors mediate the psychophysical responses to bitter compounds of hops (Humulus lupulus L.) and beer. Chemosens Percept (2009) 2(3):118-32. doi:10.1007/s12078-009-9049-1
210. Hufnagel JC, Hofmann T. Quantitative reconstruction of the nonvolatile sensometabolome of a red wine. J Agric Food Chem (2008) 56(19):9190-9. doi:10.1021/jf801742w
211. Hufnagel JC, Hofmann T. Orosensory-directed identification of astringent mouthfeel and bitter-tasting compounds in red wine. J Agric Food Chem (2008) 56(4):1376-86. doi:10.1021/jf073031n
212. Hayes JE, Wallace MR, Knopik VS, Herbstman DM, Bartoshuk LM, Duffy VB. Allelic variation in TAS2R bitter receptor genes associates with variation in sensations from and ingestive behaviors toward common bitter beverages in adults. Chem Senses (2011) 36(3):311-9. doi:10.1093/chemse/bjq132
213. Hayes JE, Feeney EL, Allen AL. Do polymorphisms in chemosensory genes matter for human ingestive behavior? Food Qual Prefer (2013) 30(2):202-16. doi:10.1016/j.foodqual.2013.05.013
214. Kaplan AR, Glanville EV, Fischer R. Taste thresholds for bitterness and cigarette smoking. Nature (1964) 202(4939):1366. doi:10.1038/2021366a0
215. Enoch MA, Harris CR, Goldman D. Does a reduced sensitivity to bitter taste increase the risk of becoming nicotine addicted? Addict Behav (2001) 26(3):399-404. doi:10.1016/S0306-4603(00)00117-9
216. Cannon DS, Baker TB, Piper ME, Scholand MB, Lawrence DL, Drayna DT, et al. Associations between phenylthiocarbamide gene polymorphisms and cigarette smoking. Nicotine Tob Res (2005) 7(6):853-8.
217. Snedecor S, Pomerleau C, Mehringer A, Ninowski R, Pomerleau O. Differences in smoking-related variables based on phenylthiocarbamide "taster" status. Addict Behav (2006) 31(12):2309-12. doi:10.1016/j.addbeh.2006.02.016
218. Mangold JE, Payne TJ, Ma JZ, Chen G, Li MD. Bitter taste receptor gene polymorphisms are an important factor in the development of nicotine dependence in African Americans. J Med Genet (2008) 45(9):578-82. doi:10.1136/jmg.2008.057844
219. Weber AM. Determining the prevalence of bitter tasters in a sample of college smokers. J Undergrad Res Ohio State (2011) 2(1).
220. Fattore L, Fratta W. How important are sex differences in cannabinoid action? Br J Pharmacol (2010) 160(3):544-8. doi:10.1111/j.1476-5381.2010.00776.x
221. Seden K, Dickinson L, Khoo S, Back D. Grapefruit-drug interactions. Drugs (2010) 70(18):2373-407. doi:10.2165/11585250-000000000-00000
222. Bartoshuk LM, Duffy VB, Miller IJ. PTC/PROP tasting: anatomy, psychophysics, and sex effects. Physiol Behav (1994) 56(6):1165-71.
223. Duffy VB, Hayes JE, Davidson AC, Kidd JR, Kidd KK, Bartoshuk LM. Vegetable intake in college-aged adults is explained by oral sensory phenotypes and TAS2R38 genotype. Chemosens Percept (2010) 3(3-4):137-48. doi:10.1007/s12078-010-9079-8
224. Feeney E. The impact of bitter perception and genotypic variation of TAS2R38 on food choice. Nutr Bull (2011) 36(1):20-33. doi:10.1111/j.1467-3010.2010.01870.x
225. Benowitz NL, Lessov-Schlaggar CN, Swan GE, Jacob P III. Female sex and oral contraceptive use accelerate nicotine metabolism. Clin Pharmacol Ther (2006) 79(5):480-8.
226. Greenblatt DJ, von Moltke LL. Gender has a small but statistically significant effect on clearance of CYP3A substrate drugs. J Clin Pharmacol (2008) 48(11):1350-5. doi:10.1177/0091270008323754
227. Nicolson TJ, Mellor HR, Roberts RR. Gender differences in drug toxicity. Trends Pharmacol Sci (2010) 31(3):108-14. doi:10.1016/j.tips.2009.12.001
228. Rando G, Wahli W. Sex differences in nuclear receptor-regulated liver metabolic pathways. Biochim Biophys Acta (2011) 1812(8):964-73. doi:10.1016/j.bbadis.2010.12.023
229. Yang L, Li Y, Hong H, Chang CW, Guo LW, Lyn-Cook B, et al. Sex differences in the expression of drug-metabolizing and transporter genes in human liver. J Drug Metab Toxicol (2012) 3:119.
230. Soldin OP, Chung SH, Mattison DR. Sex differences in drug disposition. J Biomed Biotechnol (2011) 2011:1-14. doi:10.1155/2011/187103
231. Anzenbacher P, Anzenbacherova E. Cytochromes P450 and metabolism of xenobiotics. Cell Mol Life Sci (2001) 58(5-6):737-47. doi:10.1007/PL00000897
232. Waxman DJ, Holloway MG. Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol (2009) 76(2):215-28. doi:10.1124/mol.109.056705
233. Prutkin J, Duffy VB, Etter L, Fast K, Gardner E, Lucchina LA, et al. Genetic variation and inferences about perceived taste intensity in mice and men. Physiol Behav (2000) 69(1):161-73.
234. Kölble N, Hummel T, von Mering R, Huch A, Huch R. Gustatory and olfactory function in the first trimester of pregnancy. Eur J Obstet Gynecol Reprod Biol (2001) 99(2):179-83. doi:10.1016/S0301-2115(01)00408-0
235. Flaxman SM, Sherman PW. Morning sickness: a mechanism for protecting mother and embryo. Q Rev Biol (2000) 75(2):113-48. doi:10.1086/393377
236. Fessler DMT. Reproductive immunosuppression and diet: an evolutionary perspective on pregnancy sickness and meat consumption. Curr Anthropol (2002) 43(1):19-61. doi:10.1086/324128
237. Hook EB. Dietary cravings and aversions during pregnancy. Am J Clin Nutr (1978) 31(8):1355-62.
238. Profet M. Pregnancy sickness as adaptation: a deterrent to maternal ingestion of teratogens. In: Barkow JH, Cosmides L, Tooby J, editors. Adapted Mind: Evolutionary Psychology and the Generation of Culture. New York: Oxford University Press (1995). p. 327-66.
239. Patil CL, Abrams ET, Steinmetz AR, Young SL. Appetite sensations and nausea and vomiting in pregnancy: an overview of the explanations. Ecol Food Nutr (2012) 51(5):394-417. doi:10.1080/03670244.2012.696010
240. Gill DM. Bacterial toxins: a table of lethal amounts. Microbiol Rev (1982) 46(1):86-94.
241. Pepper GV, Roberts SC. Rates of nausea and vomiting in pregnancy and dietary characteristics across populations. Proc Biol Sci (2006) 273(1601):2675-9. doi:10.1098/rspb.2006.3633
242. Pletsch PK, Pollak KI, Peterson BL, Park J, Oncken CA, Swamy GK, et al. Olfactory and gustatory sensory changes to tobacco smoke in pregnant smokers. Res Nurs Health (2008) 31(1):31-41.
243. Dempsey D, Jacob P III, Benowitz NL. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther (2002) 301(2):594-8. doi:10.1124/jpet.301.2.594
244. Choi S-Y, Koh KH, Jeong H. Isoform-specific regulation of cytochromes P450 expression by estradiol and progesterone. Drug Metab Dispos (2012) 41(2):263-9. doi:10.1124/dmd.112.046276
245. Tracy TS, Venkataramanan R, Glover DD, Caritis SN. Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy. Am J Obstet Gynecol (2005) 192(2):633-9. doi:10.1016/j.ajog.2004.08.030
246. Anderson GD. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet (2005) 44(10):989-1008. doi:10.2165/00003088-200544100-00001
247. Isoherranen N, Thummel KE. Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes? Drug Metab Dispos (2013) 41(2):256-62. doi:10.1124/dmd.112.050245
248. United Nations. World Fertility Report 2009. New York: Department of Economic and Social Affairs, Population Division (2011).
249. Cubbin C, Soobader M-J, LeClere FB. The intersection of gender and race/ethnicity in smoking behaviors among menthol and non-menthol smokers in the United States: smoking behaviors among menthol and non-menthol smokers. Addiction (2010) 105:32-8. doi:10.1111/j.1360-0443.2010.03191.x
250. Simonson R. Flavored Whiskeys Expand the Market. The New York Times (2013). Available from: http://www.nytimes.com/2013/06/26/dining/flavored-whiskeys-expand-the-market.html
251. Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet (2012) 379(9810):55-70. doi:10.1016/S0140-6736(11)61138-0
252. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med (2006) 3(11): e442. doi:10.1371/journal.pmed.0030442
253. The National Center on Addiction and Substance Abuse at Columbia University. Addiction Medicine: Closing the Gap Between Science and Practice (2012). Available from: http://www.casacolumbia.org/upload/2012/20120626addictionmed.pdf